Angiotensin AT2 receptors are reviewed to assess whether their cardiovascular effects offer genuine therapeutic hope or remain unsubstantiated hype.
Tasa de eventos absoluta: 0% vs 0%
British Journal of Pharmacology (2003) 140 , 809–824. doi: 10.1038/sj.bjp.0705448
Widdop et al. (Wed,) reported a other. Angiotensin AT2 receptors are reviewed to assess whether their cardiovascular effects offer genuine therapeutic hope or remain unsubstantiated hype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: